Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Biocartis logo — High precision diagnostics for personalized medicine

Biocartis

High precision diagnostics for personalized medicine

Founded 2007 Belgium Belgium 315 employees Grant Total: $322.90M Biotechnology, Health Care +1

General Information

Company Name Biocartis
Founded Year 2007
Location Belgium Belgium +3
Employees 315
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Grant
Social

Get notified when Biocartis moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Biocartis

Biocartis is a Belgian-based biotechnology startup founded in 2007 with a mission to revolutionize the field of molecular diagnostics. The company's slogan "High precision diagnostics for personalized medicine" encapsulates its focus on providing next generation diagnostic solutions for personalized medicine. Biocartis has gained significant attention in the industry due to its proprietary MDx Idylla™ platform, a fully automated, real-time system that offers accurate and highly reliable molecular information from any biological sample in virtually any setting. With a recent €1.20M grant investment at 30 September 2020 from Agentschap Innoveren & Ondernemen, Biocartis is advancing its efforts to address key unmet clinical needs, particularly in the oncology and infectious diseases segments. These areas represent the fastest and largest growing segments of the US$6.5 billion molecular diagnostics market, positioning Biocartis as a key player in this rapidly evolving industry. By employing over 500 individuals, Biocartis has established its headquarters in Mechelen, Belgium. The company's vision is to enable universal access to molecular testing, with a focus on making molecular testing actionable, convenient, fast, and suitable for any lab. With its innovative approach and focus on personalized medicine, Biocartis is well positioned to drive significant impact in the healthcare and biotechnology sectors. For further information about Biocartis, interested parties can visit www.biocartis.com.

Taxonomy: molecular diagnostics, personalized medicine, oncology, infectious diseases, diagnostics technology, biomolecular analysis, micro-technology platform, treatment selection, treatment monitoring, clinical practice improvement, rapid testing, precision diagnostics, innovative diagnostics

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 30 Sep 2020
Post-IPO Equity •••••• - 28 Nov 2017
Series F •••••• 3
Investor
•••• •••• 		04 Sep 2014
Grant •••••• - 26 Jun 2014
Series E •••••• 8
Investor Investor Investor Investor Investor
•••• •••• 		05 Nov 2013

View All 9 Funding Rounds

Biocartis Alternatives & Competitors

Biocartis vs
RESOLVE MOLECULAR DIAGNOSTICS LLC
RESOLVE MOLECULAR DIAGNOSTICS LLC United States

Providing genetic and molecular diagnostic solutions to advance healthcare.

5 employees
Health Care
Compare Biocartis vs RESOLVE MOLECULAR DIAGNOSTICS LLC
Biocartis vs
Qualisure Diagnostics Inc.
Qualisure Diagnostics Inc. Canada

Deploying AI-enabled molecular diagnostics globally through decentralized testing and centralized in...

Seed
10 employees
Biotechnology, Health Care
Compare Biocartis vs Qualisure Diagnostics Inc.
Biocartis vs
Veracyte, Inc.
Veracyte, Inc. United States

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

IPO
750 employees
Biotechnology, Health Care
Compare Biocartis vs Veracyte, Inc.

FAQ About Biocartis

High precision diagnostics for personalized medicine
Biocartis was founded in 2007.
Biocartis is headquartered in Belgium.
Biocartis operates in the following industries: Biotechnology, Health Care, Medical Devices.
Biocartis has approximately 315 employees.
Biocartis has completed 9 funding rounds, raising a total of $322.90M. The latest funding stage is Grant.
Top alternatives and competitors to Biocartis include RESOLVE MOLECULAR DIAGNOSTICS LLC, Qualisure Diagnostics Inc., Veracyte, Inc., Xcoo, Invivoscribe. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biocartis and RESOLVE MOLECULAR DIAGNOSTICS LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Biocartis and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy